サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1469267

整形外科計画システムの世界市場：製品タイプ、エンドユーザー、地域別（北米、欧州、アジア太平洋、ラテンアメリカ、中東アフリカ）：産業分析、規模、シェア、成長、動向、予測（2024年～2031年）

Orthopedic Planning Systems Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

出版日
ページ情報
英文 380 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.03円
整形外科計画システムの世界市場：製品タイプ、エンドユーザー、地域別（北米、欧州、アジア太平洋、ラテンアメリカ、中東アフリカ）：産業分析、規模、シェア、成長、動向、予測（2024年～2031年）
出版日: 2024年04月16日
発行: Persistence Market Research
ページ情報: 英文 380 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Research社は、整形外科計画システム市場を徹底的に分析し、その世界の展望を詳述した包括的なレポートを提供しています。この詳細な出版物は、市場力学、動向、機会、課題に関する貴重な洞察を提供し、その構造の包括的な概要を提供します。独自のデータと統計に裏打ちされた本調査では、2024年から2031年までの整形外科計画システム市場の予測成長軌道を予測しています。

2024年、整形外科計画システムの世界収益は8,615万米ドルに達し、CAGR 7.9%で成長し、2031年には1億5,820万米ドルに達すると予測されます。

主な洞察

  • 整形外科計画システムの市場規模（2024年）：8,615万米ドル
  • 予測市場価値（2031年）：1億5,820万米ドル
  • 世界市場成長率（CAGR 2024年～2032年）：7.9%

整形外科計画システム市場- 調査範囲

整形外科計画システムの世界市場は、整形外科医やヘルスケアプロバイダーに様々なソリューションを提供し、手術プランニングやインプラントの選択を容易にします。主な促進要因は、医療技術の進歩、整形外科疾患の有病率の増加、高齢化人口の増加などです。新たな動向としては、個別化医療と3Dプリンティング・アプリケーションが挙げられます。全体として、効率的な外科手術に対する需要の高まり、患者の転帰の改善、費用対効果の高いヘルスケアソリューションに対するニーズが市場を牽引しています。

市場促進要因

整形外科計画システムの採用拡大は、技術革新や低侵襲手術手技の受け入れ拡大など、相互に関連するいくつかの要因によって後押しされています。画像モダリティとコンピュータ支援手術の進歩は、手術の精度と患者の安全性を高め、整形外科プランニング・ソリューションの需要を促進しています。さらに、高齢化や肥満率の上昇といった人口動態の変化も、整形外科疾患の罹患率上昇に寄与しており、市場の成長を後押ししています。ヘルスケアプロバイダーは治療結果の最適化と合併症の最小化に努めており、整形外科計画システムは外科手術の合理化と患者ケアの強化に重要な役割を果たしています。

市場抑制要因

整形外科計画システム市場が直面する課題には、規制上のハードル、償還の制限、データセキュリティの懸念などがあります。医療機器やソフトウェアに対する厳しい規制要件の遵守は、市場参入企業にとって課題となり、研究開発や規制遵守のための多大な投資が必要となります。さらに、償還政策は地域によって異なるため、整形外科治療計画システムの導入や医療提供者の意思決定に影響を与えます。データセキュリティと患者のプライバシーに関する懸念も市場成長の障壁となっており、患者情報を保護するために強固なサイバーセキュリティ対策とデータ保護規制の遵守が必要となります。

市場機会

整形外科計画システム分野の市場成長機会には、新興市場での用途拡大、技術進歩、戦略的パートナーシップなどがあります。新興諸国では整形外科疾患の有病率が上昇しており、ヘルスケアインフラが改善され、高度医療技術へのアクセスが増加するため、市場拡大の機会が生まれます。さらに、現在進行中の3Dプリンティングと人工知能の技術革新は、整形外科計画システムの機能を強化する機会を提供し、個別化された治療アプローチと手術結果の最適化を可能にします。整形外科機器メーカー、ソフトウェア開発者、ヘルスケア機関のコラボレーションにより、整形外科医と患者の進化するニーズに対応する統合ソリューションの開発が促進されます。

レポートが回答する主な質問

  • 整形外科計画システム市場の成長を促進する主な要因は何か？
  • 整形外科計画システム市場を形成する新たな動向は何か？
  • 市場拡大を阻害する主な課題は何か、またどのように軽減できるか？
  • 整形外科計画システム分野で市場参入企業が活用できる機会には何があるか？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/ 分類
  • 市場の定義/ 範囲/ 制限
  • 包含と除外

第3章 主要な市場動向

  • 市場に影響を与える主な動向
  • 製品イノベーション/開発動向

第4章 市場背景

  • マクロ経済要因
  • 予測要因
  • 市場力学
  • 世界需給分析

第5章 COVID19の危機分析

  • COVID19の現在の統計と今後の影響の可能性
  • COVID19と影響分析
    • ソリューション別
    • 用途別
    • 展開別
    • エンドユーザー別

第6章 主要な成功要因

  • 主な発展
  • 規制シナリオ
  • 主要な取引と契約
  • 地域別手術件数

第7章 世界の整形外科計画システム市場：価格分析

  • 国別および地域別の価格分析（ソリューション別）
  • 価格の内訳
    • メーカーレベルの価格設定
    • ディストリビューターレベルの価格設定
  • 世界平均価格分析ベンチマーク

第8章 世界の整形外科計画システム市場の需要分析（2019～2023年）と予測（2024～2031年）

  • 過去の市場金額分析、2019～2023年
  • 現在および将来の市場金額予測、2024～2031年
    • 前年比成長動向分析
    • 絶対的利益の機会分析

第9章 世界の整形外科計画システム市場分析（2019～2023年）と予測（2024～2031年）、ソリューション別

  • イントロダクション/主な調査結果
  • 過去の市場規模分析、ソリューション別、2019-2023年
  • 現在および将来の市場規模分析と予測、ソリューション別、2024-2031年
    • 整形外科計画システム
      • 手術前計画ソフトウェア
        • 2Dプランニングソフトウェア
        • 3Dプランニングソフトウェア
      • 術後計画ソフトウェア
  • 市場魅力分析、ソリューション別

第10章 世界の整形外科計画システム市場分析（2019～2023年）と予測（2024～2031年）、用途別

  • イントロダクション/主な調査結果
  • 過去の市場規模分析、用途別、2019-2023年
  • 現在および将来の市場規模の分析と予測、用途別、2024-2031年
    • 整形外科
      • 関節置換術
        • 股関節置換術
        • 膝関節置換術
        • 肩関節置換術
        • 小骨置換
    • 整形外科腫瘍学
  • 市場魅力分析、用途別

第11章 世界の整形外科計画システム市場分析（2019～2023年）と予測（2024～2031年）、展開別

  • イントロダクション/主な調査結果
  • 過去の市場規模分析、展開別、2019-2023年
  • 現在および将来の市場規模の分析と予測、展開別、2024-2031年
    • ウェブベースのソフトウェア
    • クラウドベースのソフトウェア
    • オンプレミス
  • 市場魅力分析、展開別

第12章 世界の整形外科計画システム市場分析（2019～2023年）と予測（2024～2031年）、エンドユーザー別

  • イントロダクション/主な調査結果
  • 過去の市場規模分析、エンドユーザー別、2019-2023年
  • 現在および将来の市場規模の分析と予測、エンドユーザー別、2024～2031年
    • 病院
    • 外来手術センター
    • 整形外科診療所ベース
    • クリニック
  • 市場魅力分析、エンドユーザー別

第13章 世界の整形外科計画システム市場分析（2019～2023年）と予測（2024～2031年）、地域別

  • イントロダクション
  • 過去の市場規模分析、地域別、2019-2023年
  • 現在の市場規模分析と予測、地域別、2024-2031年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東およびアフリカ（MEA）
  • 市場魅力分析、地域別

第14章 北米の整形外科計画システム市場分析（2019～2023年）と予測（2024～2031年）

第15章 ラテンアメリカの整形外科計画システム市場分析（2019～2023年）と予測（2024～2031年）

第16章 欧州整形外科計画システム市場分析（2019～2023年）と予測（2024～2031年）

第17章 南アジアおよび太平洋地域の整形外科計画システム市場分析（2019～2023年）と予測（2024～2031年）

第18章 東アジアの整形外科計画システム市場分析（2019～2023年）と予測（2024～2031年）

第19章 オセアニア整形外科計画システム市場分析（2019～2023年）と予測（2024～2031年）

第20章 中東およびアフリカの整形外科計画システム市場分析（2019～2023年）と予測（2024～2031年）

第21章 主要国別の整形外科計画システム市場分析（2024～2031年）

  • イントロダクション
    • 市場金額比率分析
    • 世界と国別の成長比較
    • 国別の価格分析
  • 米国
  • カナダ
  • メキシコ
  • ブラジル
  • ドイツ
  • イタリア
  • フランス
  • 英国
  • スペイン
  • ロシア
  • 中国
  • 日本
  • 韓国
  • インド
  • ASEAN
  • オーストラリア
  • ニュージーランド
  • トルコ
  • 南アフリカ

第22章 市場構造分析

  • 市場分析：企業階層別（整形外科計画システム）
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第23章 競合分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 競合の詳細情報
    • Formus Labs Ltd
    • EOS imaging
    • Brainlab AG
    • Sectra AB
    • Stryker
    • Materialise
    • Medstrat
    • MediCAD Hectec GmbH
    • 3D Systems, Inc
    • PEEK HEALTH SA
    • Radlink, Inc.
    • SurgiNovi
    • RSA Biomedical
    • HIPOP-PLAN
    • Zimmer Biomet.
    • Optinav
    • Enhatch Inc.
    • Numex GmbH
    • Corin Group

第24章 前提条件と使用される頭字語

第25章 調査手法

目次
Product Code: PMRREP26182

Persistence Market Research has conducted a thorough analysis of the Orthopedic Planning Systems Market, providing a comprehensive report detailing its global landscape. This in-depth publication offers valuable insights into the market's dynamics, trends, opportunities, and challenges, providing a comprehensive overview of its structure. Backed by exclusive data and statistics, the research predicts the anticipated growth trajectory of the Orthopedic Planning Systems Market spanning from 2024 to 2031.

In 2024, global revenue from orthopedic planning systems reached US$ 86.15 million, projected to grow at a CAGR of 7.9%, reaching US$ 158.2 million by 2031.

Key Insights:

  • Orthopedic Planning Systems Market Size (2024): US$ 86.15 Mn
  • Projected Market Value (2031): US$ 158.2 Mn
  • Global Market Growth Rate (2024-2031): 7.9% CAGR

Orthopedic Planning Systems Market - Report Scope

The global orthopedic planning systems market offers various solutions for orthopedic surgeons and healthcare providers, facilitating surgical planning and implant selection. Key drivers include advancements in medical technology, increasing prevalence of orthopedic disorders, and the growing aging population. Emerging trends focus on personalized medicine and 3D printing applications. Overall, the market is driven by the rising demand for efficient surgical procedures, improved patient outcomes, and the need for cost-effective healthcare solutions.

Market Growth Drivers

The expanding adoption of orthopedic planning systems is fueled by several interconnected factors, including technological innovation and the growing acceptance of minimally invasive surgical techniques. Advances in imaging modalities and computer-assisted surgery enhance surgical accuracy and patient safety, driving the demand for orthopedic planning solutions. Additionally, demographic shifts, such as an aging population and rising obesity rates, contribute to the increasing incidence of orthopedic conditions, boosting market growth. As healthcare providers strive to optimize treatment outcomes and minimize complications, orthopedic planning systems play a crucial role in streamlining surgical procedures and enhancing patient care.

Market Restraints

Challenges facing the orthopedic planning systems market include regulatory hurdles, reimbursement limitations, and data security concerns. Compliance with stringent regulatory requirements for medical devices and software poses challenges for market players, necessitating substantial investments in research and development and regulatory compliance efforts. Moreover, reimbursement policies vary across regions, impacting the adoption of orthopedic planning systems and healthcare provider decisions. Data security and patient privacy concerns also present barriers to market growth, requiring robust cybersecurity measures and compliance with data protection regulations to safeguard patient information.

Opportunities

Opportunities for market growth in the orthopedic planning systems segment include expanding applications in emerging markets, technological advancements, and strategic partnerships. The rising prevalence of orthopedic disorders in developing countries creates opportunities for market expansion, as healthcare infrastructure improves and access to advanced medical technologies increases. Furthermore, ongoing innovations in 3D printing and artificial intelligence offer opportunities to enhance the capabilities of orthopedic planning systems, enabling personalized treatment approaches and optimizing surgical outcomes. Collaborations between orthopedic device manufacturers, software developers, and healthcare institutions facilitate the development of integrated solutions that address the evolving needs of orthopedic surgeons and patients.

Key Questions Answered in Report::

  • What are the key drivers propelling the growth of the orthopedic planning systems market?
  • What emerging trends are shaping the landscape of orthopedic planning systems?
  • What are the primary challenges hindering market expansion, and how can they be mitigated?
  • What opportunities exist for market players to capitalize on in the orthopedic planning systems segment?

Competitive Intelligence and Business Strategy

In October 2020, EOS imaging installed its first EOSedge(TM) system at the Macquarie University Hospital in Australia, marking a significant milestone for the company in expanding its market presence.

In December 2020, Zimmer Biomet bolstered its product offerings by acquiring A&E Medical, gaining access to a diverse portfolio of sternal closure devices, including cable systems and sternal sutures.

In April 2020, Brainlab achieved CE Mark approval for its advanced patient positioning and monitoring system, ExacTrac(R) Dynamic, demonstrating its commitment to innovation and meeting regulatory standards.

Key Companies Profiled

  • Formus Labs Ltd,
  • EOS imaging,
  • Brainlab AG,
  • Sectra AB,
  • Stryker,
  • Materialise,
  • Medstrat,
  • mediCAD Hectec GmbH,
  • 3D Systems, Inc.,
  • PEEK HEALTH S.A,
  • Radlink, Inc.,
  • SurgiNovi,
  • RSA Biomedical,
  • HIPOP-PLAN,
  • Zimmer Biomet,
  • Optinav,
  • Enhatch Inc.,

Key Segments Covered in Orthopedic Planning Systems Industry Research

Orthopedic Planning Systems Market by Solution:

  • Pre-Surgical Planning Software

o2D Planning Software

o3D Planning Software

  • Post-Surgical Planning Software

Orthopedic Planning Systems Market by Application:

  • Joint Replacement

oHip Replacement

oKnee Replacement

oShoulder Replacement

oSmall Bone Replacement

  • Orthopaedic Oncology

Orthopedic Planning Systems Market by Deployment:

  • Web Based Software
  • Cloud Based Software
  • On Premises

Orthopedic Planning Systems Market by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Orthopaedic Office-Based Clinics

Orthopedic Planning Systems Market by Region:

  • North America Orthopedic Planning Systems Market
  • Latin America Orthopedic Planning Systems Market
  • Europe Orthopedic Planning Systems Market
  • South Asia Orthopedic Planning Systems Market
  • East Asia Orthopedic Planning Systems Market
  • Oceania Orthopedic Planning Systems Market
  • Middle East & Africa Orthopedic Planning Systems Market

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusion and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Market Background

  • 4.1. Macro-Economic factors
    • 4.1.1. Global Healthcare Market Outlook
    • 4.1.2. Healthcare IT Spending Outlook, By U.S. & Global
    • 4.1.3. U.S. per-Capita Healthcare Expenditure
  • 4.2. Forecast Factors
    • 4.2.1. Evaluation of Incremental Costs and Effectiveness
    • 4.2.2. Increasing Spending on Healthcare Per Capita
    • 4.2.3. Increasing Spending for Healthcare Infrastructure Development Post COVID-19 Pandemic
    • 4.2.4. Application of biomedical and nanotechnology in Orthopaedics
  • 4.3. Market Dynamics
    • 4.3.1. Demand
    • 4.3.2. Restraints
    • 4.3.3. Opportunity
  • 4.4. Global Supply Demand Analysis

5. COVID19 Crisis Analysis

  • 5.1. Current COVID19 Statistics and Probable Future Impact
  • 5.2. COVID19 and Impact Analysis
    • 5.2.1. By Solution
    • 5.2.2. By Application
    • 5.2.3. By Deployment
    • 5.2.4. By End User

6. Key Success Factors

  • 6.1. Key Developments
  • 6.2. Regulatory Scenario
  • 6.3. Key Deals and Contracts
  • 6.4. Number of Surgeries, By Region

7. Global Orthopedic Planning Systems Market - Pricing Analysis

  • 7.1. Country-wise & Regional Pricing Analysis, By Solution
  • 7.2. Pricing Break-up
    • 7.2.1. Manufacturer Level Pricing
    • 7.2.2. Distributor Level Pricing
  • 7.3. Global Average Pricing Analysis Benchmark

8. Global Orthopedic Planning Systems Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2031

  • 8.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 8.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
    • 8.2.1. Y-o-Y Growth Trend Analysis
    • 8.2.2. Absolute $ Opportunity Analysis

9. Global Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031, by Solution

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Solution, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Solution, 2024-2031
    • 9.3.1. Orthopedic Planning Systems
      • 9.3.1.1. Pre-Surgical Planning Software
        • 9.3.1.1.1. 2D Planning Software
        • 9.3.1.1.2. 3D Planning Software
      • 9.3.1.2. Post-Surgical Planning Software
  • 9.4. Market Attractiveness Analysis, By Solution

10. Global Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031, by Application

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
    • 10.3.1. Orthopedic Surgery
      • 10.3.1.1. Joint Replacement
        • 10.3.1.1.1. Hip Replacement
        • 10.3.1.1.2. Knee Replacement
        • 10.3.1.1.3. Shoulder Replacement
        • 10.3.1.1.4. Small Bone Replacement
    • 10.3.2. Orthopedic Oncology
  • 10.4. Market Attractiveness Analysis, By Application

11. Global Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031, by Deployment

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Deployment, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Deployment, 2024-2031
    • 11.3.1. Web Based Software
    • 11.3.2. Cloud Based Software
    • 11.3.3. On Premises
  • 11.4. Market Attractiveness Analysis, By Deployment

12. Global Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031, by End User

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
    • 12.3.1. Hospitals
    • 12.3.2. Ambulatory Surgical Centres
    • 12.3.3. Orthopedic Office-Based
    • 12.3.4. Clinics
  • 12.4. Market Attractiveness Analysis, By End User

13. Global Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031, by Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2023
  • 13.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2024-2031
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. East Asia
    • 13.3.5. South Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa (MEA)
  • 13.4. Market Attractiveness Analysis, By Region

14. North America Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

  • 14.1. Introduction
  • 14.2. Pricing Analysis
  • 14.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
  • 14.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
    • 14.4.1. By Country
      • 14.4.1.1. U.S.
      • 14.4.1.2. Canada
    • 14.4.2. By Solution
    • 14.4.3. By Application
    • 14.4.4. By Deployment
    • 14.4.5. By End User
  • 14.5. Market Attractiveness Analysis
    • 14.5.1. By Country
    • 14.5.2. By Solution
    • 14.5.3. By Application
    • 14.5.4. By Deployment
    • 14.5.5. By End User
  • 14.6. Market Trends
  • 14.7. Key Market Participants - Intensity Mapping
  • 14.8. Drivers and Restraints - Impact Analysis

15. Latin America Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

  • 15.1. Introduction
  • 15.2. Pricing Analysis
  • 15.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
  • 15.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
    • 15.4.1. By Country
      • 15.4.1.1. Brazil
      • 15.4.1.2. Mexico
      • 15.4.1.3. Rest of Latin America
    • 15.4.2. By Solution
    • 15.4.3. By Application
    • 15.4.4. By Deployment
    • 15.4.5. By End User
  • 15.5. Market Attractiveness Analysis
    • 15.5.1. By Country
    • 15.5.2. By Solution
    • 15.5.3. By Application
    • 15.5.4. By Deployment
    • 15.5.5. By End User
  • 15.6. Market Trends
  • 15.7. Key Market Participants - Intensity Mapping
  • 15.8. Drivers and Restraints - Impact Analysis

16. Europe Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

  • 16.1. Introduction
  • 16.2. Pricing Analysis
  • 16.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
  • 16.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
    • 16.4.1. By Country
      • 16.4.1.1. Germany
      • 16.4.1.2. Italy
      • 16.4.1.3. France
      • 16.4.1.4. U.K.
      • 16.4.1.5. Spain
      • 16.4.1.6. BENELUX
      • 16.4.1.7. Russia
      • 16.4.1.8. Rest of Europe
    • 16.4.2. By Solution
    • 16.4.3. By Application
    • 16.4.4. By Deployment
    • 16.4.5. By End User
  • 16.5. Market Attractiveness Analysis
    • 16.5.1. By Country
    • 16.5.2. By Solution
    • 16.5.3. By Application
    • 16.5.4. By Deployment
    • 16.5.5. By End User
  • 16.6. Market Trends
  • 16.7. Key Market Participants - Intensity Mapping
  • 16.8. Drivers and Restraints - Impact Analysis

17. South Asia and Pacific Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

  • 17.1. Introduction
  • 17.2. Pricing Analysis
  • 17.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
  • 17.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
    • 17.4.1. By Country
      • 17.4.1.1. India
      • 17.4.1.2. ASEAN
      • 17.4.1.3. Oceania
      • 17.4.1.4. Rest of South Asia & Pacific
    • 17.4.2. By Solution
    • 17.4.3. By Application
    • 17.4.4. By Deployment
    • 17.4.5. By End User
  • 17.5. Market Attractiveness Analysis
    • 17.5.1. By Country
    • 17.5.2. By Solution
    • 17.5.3. By Application
    • 17.5.4. By Deployment
    • 17.5.5. By End User
  • 17.6. Market Trends
  • 17.7. Key Market Participants - Intensity Mapping
  • 17.8. Drivers and Restraints - Impact Analysis

18. East Asia Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

  • 18.1. Introduction
  • 18.2. Pricing Analysis
  • 18.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
  • 18.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
    • 18.4.1. By Country
      • 18.4.1.1. China
      • 18.4.1.2. Japan
      • 18.4.1.3. South Korea
    • 18.4.2. By Solution
    • 18.4.3. By Application
    • 18.4.4. By Deployment
    • 18.4.5. By End User
  • 18.5. Market Attractiveness Analysis
    • 18.5.1. By Country
    • 18.5.2. By Solution
    • 18.5.3. By Application
    • 18.5.4. By Deployment
    • 18.5.5. By End User
  • 18.6. Market Trends
  • 18.7. Key Market Participants - Intensity Mapping
  • 18.8. Drivers and Restraints - Impact Analysis

19. Oceania Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

  • 19.1. Introduction
  • 19.2. Pricing Analysis
  • 19.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
  • 19.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
    • 19.4.1. By Country
      • 19.4.1.1. Australia
      • 19.4.1.2. New Zealand
    • 19.4.2. By Solution
    • 19.4.3. By Application
    • 19.4.4. By Deployment
    • 19.4.5. By End User
  • 19.5. Market Attractiveness Analysis
    • 19.5.1. By Country
    • 19.5.2. By Solution
    • 19.5.3. By Application
    • 19.5.4. By Deployment
    • 19.5.5. By End User
  • 19.6. Market Trends
  • 19.7. Key Market Participants - Intensity Mapping
  • 19.8. Drivers and Restraints - Impact Analysis

20. Middle East and Africa Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

  • 20.1. Introduction
  • 20.2. Pricing Analysis
  • 20.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
  • 20.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
    • 20.4.1. By Country
      • 20.4.1.1. GCC Countries
      • 20.4.1.2. Turkey
      • 20.4.1.3. Northern Africa
      • 20.4.1.4. South Africa
      • 20.4.1.5. Rest of Middle East and Africa
    • 20.4.2. By Solution
    • 20.4.3. By Application
    • 20.4.4. By Deployment
    • 20.4.5. By End User
  • 20.5. Market Attractiveness Analysis
    • 20.5.1. By Country
    • 20.5.2. By Solution
    • 20.5.3. By Application
    • 20.5.4. By Deployment
    • 20.5.5. By End User
  • 20.6. Market Trends
  • 20.7. Key Market Participants - Intensity Mapping
  • 20.8. Drivers and Restraints - Impact Analysis

21. Country Level Orthopedic Planning Systems Market Analysis 2024-2031

  • 21.1. Introduction
    • 21.1.1. Market Value Proportion Analysis
    • 21.1.2. Global VS. Country Growth Comparison
    • 21.1.3. Pricing Analysis, by Country
  • 21.2. U.S. Orthopedic Planning Systems Market Analysis
    • 21.2.1. By Solution
    • 21.2.2. By Application
    • 21.2.3. By Deployment
    • 21.2.4. By End User
  • 21.3. Canada Orthopedic Planning Systems Market Analysis
    • 21.3.1. By Solution
    • 21.3.2. By Application
    • 21.3.3. By Deployment
    • 21.3.4. By End User
  • 21.4. Mexico Orthopedic Planning Systems Market Analysis
    • 21.4.1. By Solution
    • 21.4.2. By Application
    • 21.4.3. By Deployment
    • 21.4.4. By End User
  • 21.5. Brazil Orthopedic Planning Systems Market Analysis
    • 21.5.1. By Solution
    • 21.5.2. By Application
    • 21.5.3. By Deployment
    • 21.5.4. By End User
  • 21.6. Germany Orthopedic Planning Systems Market Analysis
    • 21.6.1. By Solution
    • 21.6.2. By Application
    • 21.6.3. By Deployment
    • 21.6.4. By End User
  • 21.7. Italy Orthopedic Planning Systems Market Analysis
    • 21.7.1. By Solution
    • 21.7.2. By Application
    • 21.7.3. By Deployment
    • 21.7.4. By End User
  • 21.8. France Orthopedic Planning Systems Market Analysis
    • 21.8.1. By Solution
    • 21.8.2. By Application
    • 21.8.3. By Deployment
    • 21.8.4. By End User
  • 21.9. U.K. Orthopedic Planning Systems Market Analysis
    • 21.9.1. By Solution
    • 21.9.2. By Application
    • 21.9.3. By Deployment
    • 21.9.4. By End User
  • 21.10. Spain Orthopedic Planning Systems Market Analysis
    • 21.10.1. By Solution
    • 21.10.2. By Application
    • 21.10.3. By Deployment
    • 21.10.4. By End User
  • 21.11. Russia Orthopedic Planning Systems Market Analysis
    • 21.11.1. By Solution
    • 21.11.2. By Application
    • 21.11.3. By Deployment
    • 21.11.4. By End User
  • 21.12. China Orthopedic Planning Systems Market Analysis
    • 21.12.1. By Solution
    • 21.12.2. By Application
    • 21.12.3. By Deployment
    • 21.12.4. By End User
  • 21.13. Japan Orthopedic Planning Systems Market Analysis
    • 21.13.1. By Solution
    • 21.13.2. By Application
    • 21.13.3. By Deployment
    • 21.13.4. By End User
  • 21.14. S. Korea Orthopedic Planning Systems Market Analysis
    • 21.14.1. By Solution
    • 21.14.2. By Application
    • 21.14.3. By Deployment
    • 21.14.4. By End User
  • 21.15. India Orthopedic Planning Systems Market Analysis
    • 21.15.1. By Solution
    • 21.15.2. By Application
    • 21.15.3. By Deployment
    • 21.15.4. By End User
  • 21.16. ASEAN Orthopedic Planning Systems Market Analysis
    • 21.16.1. By Solution
    • 21.16.2. By Application
    • 21.16.3. By Deployment
    • 21.16.4. By End User
  • 21.17. Australia Orthopedic Planning Systems Market Analysis
    • 21.17.1. By Solution
    • 21.17.2. By Application
    • 21.17.3. By Deployment
    • 21.17.4. By End User
  • 21.18. New Zealand Orthopedic Planning Systems Market Analysis
    • 21.18.1. By Solution
    • 21.18.2. By Application
    • 21.18.3. By Deployment
    • 21.18.4. By End User
  • 21.19. Turkey Orthopedic Planning Systems Market Analysis
    • 21.19.1. By Solution
    • 21.19.2. By Application
    • 21.19.3. By Deployment
    • 21.19.4. By End User
  • 21.20. South Africa Orthopedic Planning Systems Market Analysis
    • 21.20.1. By Solution
    • 21.20.2. By Application
    • 21.20.3. By Deployment
    • 21.20.4. By End User

22. Market Structure Analysis

  • 22.1. Market Analysis, By Tier of Companies (Orthopedic Planning Systems)
  • 22.2. Market Share Analysis of Top Players
  • 22.3. Market Presence Analysis
    • 22.3.1. By Regional footprint of Players
    • 22.3.2. Device foot print by Players
    • 22.3.3. Channel Foot Print by Players

23. Competition Analysis

  • 23.1. Competition Dashboard
  • 23.2. Competition Benchmarking
  • 23.3. Competition Deep Dive
    • 23.3.1. Formus Labs Ltd
      • 23.3.1.1. Overview & Key financials
      • 23.3.1.2. Product Portfolio
      • 23.3.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.1.4. SWOT Analysis
      • 23.3.1.5. Sales Footprint
      • 23.3.1.6. Strategy Overview
      • 23.3.1.7. Sales and Marketing strategies
      • 23.3.1.8. Channel Strategies
    • 23.3.2. EOS imaging
      • 23.3.2.1. Overview & Key financials
      • 23.3.2.2. Product Portfolio
      • 23.3.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.2.4. SWOT Analysis
      • 23.3.2.5. Sales Footprint
      • 23.3.2.6. Strategy Overview
      • 23.3.2.7. Sales and Marketing strategies
      • 23.3.2.8. Channel Strategies
    • 23.3.3. Brainlab AG
      • 23.3.3.1. Overview & Key financials
      • 23.3.3.2. Product Portfolio
      • 23.3.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.3.4. SWOT Analysis
      • 23.3.3.5. Sales Footprint
      • 23.3.3.6. Strategy Overview
      • 23.3.3.7. Sales and Marketing strategies
      • 23.3.3.8. Channel Strategies
    • 23.3.4. Sectra AB
      • 23.3.4.1. Overview & Key financials
      • 23.3.4.2. Product Portfolio
      • 23.3.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.4.4. SWOT Analysis
      • 23.3.4.5. Sales Footprint
      • 23.3.4.6. Strategy Overview
      • 23.3.4.7. Sales and Marketing strategies
      • 23.3.4.8. Channel Strategies
    • 23.3.5. Stryker
      • 23.3.5.1. Overview & Key financials
      • 23.3.5.2. Product Portfolio
      • 23.3.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.5.4. SWOT Analysis
      • 23.3.5.5. Sales Footprint
      • 23.3.5.6. Strategy Overview
      • 23.3.5.7. Sales and Marketing strategies
      • 23.3.5.8. Channel Strategies
    • 23.3.6. Materialise
      • 23.3.6.1. Overview & Key financials
      • 23.3.6.2. Product Portfolio
      • 23.3.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.6.4. SWOT Analysis
      • 23.3.6.5. Sales Footprint
      • 23.3.6.6. Strategy Overview
      • 23.3.6.7. Sales and Marketing strategies
      • 23.3.6.8. Channel Strategies
    • 23.3.7. Medstrat
      • 23.3.7.1. Overview & Key financials
      • 23.3.7.2. Product Portfolio
      • 23.3.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.7.4. SWOT Analysis
      • 23.3.7.5. Sales Footprint
      • 23.3.7.6. Strategy Overview
      • 23.3.7.7. Sales and Marketing strategies
      • 23.3.7.8. Channel Strategies
    • 23.3.8. MediCAD Hectec GmbH
      • 23.3.8.1. Overview & Key financials
      • 23.3.8.2. Product Portfolio
      • 23.3.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.8.4. SWOT Analysis
      • 23.3.8.5. Sales Footprint
      • 23.3.8.6. Strategy Overview
      • 23.3.8.7. Sales and Marketing strategies
      • 23.3.8.8. Channel Strategies
    • 23.3.9. 3D Systems, Inc
      • 23.3.9.1. Overview & Key financials
      • 23.3.9.2. Product Portfolio
      • 23.3.9.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.9.4. SWOT Analysis
      • 23.3.9.5. Sales Footprint
      • 23.3.9.6. Strategy Overview
      • 23.3.9.7. Sales and Marketing strategies
      • 23.3.9.8. Channel Strategies
    • 23.3.10. PEEK HEALTH S.A
      • 23.3.10.1. Overview & Key financials
      • 23.3.10.2. Product Portfolio
      • 23.3.10.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.10.4. SWOT Analysis
      • 23.3.10.5. Sales Footprint
      • 23.3.10.6. Strategy Overview
      • 23.3.10.7. Sales and Marketing strategies
      • 23.3.10.8. Channel Strategies
    • 23.3.11. Radlink, Inc.
      • 23.3.11.1. Overview & Key financials
      • 23.3.11.2. Product Portfolio
      • 23.3.11.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.11.4. SWOT Analysis
      • 23.3.11.5. Sales Footprint
      • 23.3.11.6. Strategy Overview
      • 23.3.11.7. Sales and Marketing strategies
      • 23.3.11.8. Channel Strategies
    • 23.3.12. SurgiNovi
      • 23.3.12.1. Overview & Key financials
      • 23.3.12.2. Product Portfolio
      • 23.3.12.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.12.4. SWOT Analysis
      • 23.3.12.5. Sales Footprint
      • 23.3.12.6. Strategy Overview
      • 23.3.12.7. Sales and Marketing strategies
      • 23.3.12.8. Channel Strategies
    • 23.3.13. RSA Biomedical
      • 23.3.13.1. Overview & Key financials
      • 23.3.13.2. Product Portfolio
      • 23.3.13.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.13.4. SWOT Analysis
      • 23.3.13.5. Sales Footprint
      • 23.3.13.6. Strategy Overview
      • 23.3.13.7. Sales and Marketing strategies
      • 23.3.13.8. Channel Strategies
    • 23.3.14. HIPOP-PLAN
      • 23.3.14.1. Overview & Key financials
      • 23.3.14.2. Product Portfolio
      • 23.3.14.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.14.4. SWOT Analysis
      • 23.3.14.5. Sales Footprint
      • 23.3.14.6. Strategy Overview
      • 23.3.14.7. Sales and Marketing strategies
      • 23.3.14.8. Channel Strategies
    • 23.3.15. Zimmer Biomet.
      • 23.3.15.1. Overview & Key financials
      • 23.3.15.2. Product Portfolio
      • 23.3.15.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.15.4. SWOT Analysis
      • 23.3.15.5. Sales Footprint
      • 23.3.15.6. Strategy Overview
      • 23.3.15.7. Sales and Marketing strategies
      • 23.3.15.8. Channel Strategies
    • 23.3.16. Optinav
      • 23.3.16.1. Overview & Key financials
      • 23.3.16.2. Product Portfolio
      • 23.3.16.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.16.4. SWOT Analysis
      • 23.3.16.5. Sales Footprint
      • 23.3.16.6. Strategy Overview
      • 23.3.16.7. Sales and Marketing strategies
      • 23.3.16.8. Channel Strategies
    • 23.3.17. Enhatch Inc.
      • 23.3.17.1. Overview & Key financials
      • 23.3.17.2. Product Portfolio
      • 23.3.17.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.17.4. SWOT Analysis
      • 23.3.17.5. Sales Footprint
      • 23.3.17.6. Strategy Overview
      • 23.3.17.7. Sales and Marketing strategies
      • 23.3.17.8. Channel Strategies
    • 23.3.18. Numex GmbH
      • 23.3.18.1. Overview & Key financials
      • 23.3.18.2. Product Portfolio
      • 23.3.18.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.18.4. SWOT Analysis
      • 23.3.18.5. Sales Footprint
      • 23.3.18.6. Strategy Overview
      • 23.3.18.7. Sales and Marketing strategies
      • 23.3.18.8. Channel Strategies
    • 23.3.19. Corin Group
      • 23.3.19.1. Overview & Key financials
      • 23.3.19.2. Product Portfolio
      • 23.3.19.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.19.4. SWOT Analysis
      • 23.3.19.5. Sales Footprint
      • 23.3.19.6. Strategy Overview
      • 23.3.19.7. Sales and Marketing strategies
      • 23.3.19.8. Channel Strategies

24. Assumptions and Acronyms Used

25. Research Methodology